FLT3 and familial dilated cardiomyopathy: Pathway analysis identified multiple differentially regulated pathways upregulated (MAPK, FLT3, HIPPO/YAP and GCPR signaling) and downregulated (metabolism) in DCM (Extended Data Fig. 6).